hucmscs Search Results


90
ScienCell hucmscs
Hucmscs, supplied by ScienCell, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hucmscs/pmc03185192-162-0-4?v=ScienCell
Average 90 stars, based on 1 article reviews
hucmscs - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Cyagen Biosciences hucmscs complete medium
HUCMSC-CM promoted HUVECs migration, proliferation, and tubule formation in vitro. The conditional medium of <t>HUCMSCs</t> could promote the migration ( A ), proliferation ( B ) and tubule formation ( C ) of HUVECs. Scale bars = 100 μm
Hucmscs Complete Medium, supplied by Cyagen Biosciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hucmscs/pmc08900416-49-21-24?v=Cyagen+Biosciences
Average 90 stars, based on 1 article reviews
hucmscs complete medium - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Lonza hucmscs
hUVECs with <t>hUCMSCs,</t> hiPSC-MSCs, hESC-MSCs and hBMSCs had capillary-like structures. (A–D) Typical fluorescent images of coculture at 6 weeks with microcapillary structures on macroporous CPC-RGD. (E) Cumulative microcapillary length per scaffold surface area (mean ± sd; n = 5). hUCMSCs = UCM. hUVECs = EC. hiPSC-MSCs = iPM. hESC-MSCs = ESM. hBMSCs = BM. Week = w. Values that share the same letter (for example, the four groups at 6 weeks share the same letter a) are not significantly different from each other (p > 0.1). Values indicated by different letters (without any letter that is the same) are significantly different from each other (p < 0.05).
Hucmscs, supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hucmscs/pmc05807240-92-29-33?v=Lonza
Average 90 stars, based on 1 article reviews
hucmscs - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
ScienCell hucmscs (7530
hUVECs with <t>hUCMSCs,</t> hiPSC-MSCs, hESC-MSCs and hBMSCs had capillary-like structures. (A–D) Typical fluorescent images of coculture at 6 weeks with microcapillary structures on macroporous CPC-RGD. (E) Cumulative microcapillary length per scaffold surface area (mean ± sd; n = 5). hUCMSCs = UCM. hUVECs = EC. hiPSC-MSCs = iPM. hESC-MSCs = ESM. hBMSCs = BM. Week = w. Values that share the same letter (for example, the four groups at 6 weeks share the same letter a) are not significantly different from each other (p > 0.1). Values indicated by different letters (without any letter that is the same) are significantly different from each other (p < 0.05).
Hucmscs (7530, supplied by ScienCell, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hucmscs/ppr0383745-31-5-8?v=ScienCell
Average 90 stars, based on 1 article reviews
hucmscs (7530 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Pro-cell Co Ltd human umbilical cord mesenchymal stem cells (hucmscs
hUVECs with <t>hUCMSCs,</t> hiPSC-MSCs, hESC-MSCs and hBMSCs had capillary-like structures. (A–D) Typical fluorescent images of coculture at 6 weeks with microcapillary structures on macroporous CPC-RGD. (E) Cumulative microcapillary length per scaffold surface area (mean ± sd; n = 5). hUCMSCs = UCM. hUVECs = EC. hiPSC-MSCs = iPM. hESC-MSCs = ESM. hBMSCs = BM. Week = w. Values that share the same letter (for example, the four groups at 6 weeks share the same letter a) are not significantly different from each other (p > 0.1). Values indicated by different letters (without any letter that is the same) are significantly different from each other (p < 0.05).
Human Umbilical Cord Mesenchymal Stem Cells (Hucmscs, supplied by Pro-cell Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hucmscs/pmc10442716-47-0-15?v=Pro-cell+Co+Ltd
Average 90 stars, based on 1 article reviews
human umbilical cord mesenchymal stem cells (hucmscs - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Micromass UK Limited culture of hucmscs
Identification of JD-312 as compound that promotes cartilage differentiation A) Schematic of drug screening strategy. B) JD-312 increases chondrocyte-specific gene expression in <t>hUCMSCs</t> (JD-312, 10 μM. KGN, 10 μM). Cells were incubated for 7 days to detect mRNA expression levels via RT-qPCR (n = 3). Type II Collagen, Col2a1 . Aggrecan, Acan . C) The protein levels of Col2 and ACAN in hUCMSCs were analysed by western blotting. D) Effect of JD-312 on cell viability of hUCMSCs detected by CCK8 assay (n = 3).
Culture Of Hucmscs, supplied by Micromass UK Limited, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hucmscs/pmc10805627-143-6-3?v=Micromass+UK+Limited
Average 90 stars, based on 1 article reviews
culture of hucmscs - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
STEMCELL Technologies Inc cell lines of hucmscs
Identification of JD-312 as compound that promotes cartilage differentiation A) Schematic of drug screening strategy. B) JD-312 increases chondrocyte-specific gene expression in <t>hUCMSCs</t> (JD-312, 10 μM. KGN, 10 μM). Cells were incubated for 7 days to detect mRNA expression levels via RT-qPCR (n = 3). Type II Collagen, Col2a1 . Aggrecan, Acan . C) The protein levels of Col2 and ACAN in hUCMSCs were analysed by western blotting. D) Effect of JD-312 on cell viability of hUCMSCs detected by CCK8 assay (n = 3).
Cell Lines Of Hucmscs, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hucmscs/pm28279229-65-6-12?v=STEMCELL+Technologies+Inc
Average 90 stars, based on 1 article reviews
cell lines of hucmscs - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
NanoSight ltd particle size distribution of hucmscs-evs
Identification of JD-312 as compound that promotes cartilage differentiation A) Schematic of drug screening strategy. B) JD-312 increases chondrocyte-specific gene expression in <t>hUCMSCs</t> (JD-312, 10 μM. KGN, 10 μM). Cells were incubated for 7 days to detect mRNA expression levels via RT-qPCR (n = 3). Type II Collagen, Col2a1 . Aggrecan, Acan . C) The protein levels of Col2 and ACAN in hUCMSCs were analysed by western blotting. D) Effect of JD-312 on cell viability of hUCMSCs detected by CCK8 assay (n = 3).
Particle Size Distribution Of Hucmscs Evs, supplied by NanoSight ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hucmscs/pmc09288728-156-5-8?v=NanoSight+ltd
Average 90 stars, based on 1 article reviews
particle size distribution of hucmscs-evs - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
STEMCELL Technologies Inc human umbilical cord mesenchymal stem cells thefrozen hucmscs
Identification of JD-312 as compound that promotes cartilage differentiation A) Schematic of drug screening strategy. B) JD-312 increases chondrocyte-specific gene expression in <t>hUCMSCs</t> (JD-312, 10 μM. KGN, 10 μM). Cells were incubated for 7 days to detect mRNA expression levels via RT-qPCR (n = 3). Type II Collagen, Col2a1 . Aggrecan, Acan . C) The protein levels of Col2 and ACAN in hUCMSCs were analysed by western blotting. D) Effect of JD-312 on cell viability of hUCMSCs detected by CCK8 assay (n = 3).
Human Umbilical Cord Mesenchymal Stem Cells Thefrozen Hucmscs, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hucmscs/10__32508_slash_stdj__v24i4__2560-44-0-11?v=STEMCELL+Technologies+Inc
Average 90 stars, based on 1 article reviews
human umbilical cord mesenchymal stem cells thefrozen hucmscs - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
BioResource International Inc hucmscs
(A) Cell wound healing assay for IL-1β stimulated <t>mesenchymal</t> stem cells in the presence or absence of 2 μg/ml IL-1RA (IL-1β inhibitor) at 12 and 24 hours. Scale bars = 300 μm. (B) The wound area of hUCMSCs were indicated by MetaMorph and the data were normalized with control and shown as the mean ± SD (n = 3, *P<0.05, **P<0.01 versus control cells, #p<0.05, ##p<0.01 versus IL-1β treated cells). (C) Cell viability assay for IL-1β stimulation. Data were quantified by multimode micro-plate readers. Data are shown as the mean ± SD (n = 3) (N.S.: nonsignificance).
Hucmscs, supplied by BioResource International Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hucmscs/pmc08139494-34-0-11?v=BioResource+International+Inc
Average 90 stars, based on 1 article reviews
hucmscs - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
STEMCELL Technologies Inc hucmscs line
A: CM-Dil-labeled 3rd passage <t>hucMSCs</t> (×100); B: CM-Dil-labeled hucMSCs (×100) 7d later; C: CM-Dil-labeled hucMSCs membrane (×200).
Hucmscs Line, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hucmscs/pmc07840375-95-5-12?v=STEMCELL+Technologies+Inc
Average 90 stars, based on 1 article reviews
hucmscs line - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Becton Dickinson hucmscs assay kit
A: CM-Dil-labeled 3rd passage <t>hucMSCs</t> (×100); B: CM-Dil-labeled hucMSCs (×100) 7d later; C: CM-Dil-labeled hucMSCs membrane (×200).
Hucmscs Assay Kit, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hucmscs/ppr0528544-63-15-18?v=Becton+Dickinson
Average 90 stars, based on 1 article reviews
hucmscs assay kit - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

Image Search Results


HUCMSC-CM promoted HUVECs migration, proliferation, and tubule formation in vitro. The conditional medium of HUCMSCs could promote the migration ( A ), proliferation ( B ) and tubule formation ( C ) of HUVECs. Scale bars = 100 μm

Journal: Stem Cell Research & Therapy

Article Title: Human umbilical cord mesenchymal stem cell promotes angiogenesis via integrin β1/ERK1/2/HIF-1α/VEGF-A signaling pathway for off-the-shelf breast tissue engineering

doi: 10.1186/s13287-022-02770-x

Figure Lengend Snippet: HUCMSC-CM promoted HUVECs migration, proliferation, and tubule formation in vitro. The conditional medium of HUCMSCs could promote the migration ( A ), proliferation ( B ) and tubule formation ( C ) of HUVECs. Scale bars = 100 μm

Article Snippet: Cells were cultured at 37 °C in 5% CO 2 95% air-humidified incubator, harvested using 0.05% trypsin, centrifuged and resuspended in hUCMSCs complete medium (Cyagen Biosciences, USA).

Techniques: Migration, In Vitro

HUCMSCs transplantation promoted the survival of adipose tissue in fat graft without breast scaffold. A After 12 weeks of implantation, all the tissue was measured and photographed. The retention rates of grafted fat in the Low hUCMSC group and Medium hUCMSC group were significantly higher than that of the Control group (* P < 0.05, ** P < 0.001). B HE staining of fat tissue after 12 weeks of implantation (black arrows: fibrosis; stars: cysts or vacuoles; red arrows: blood vessels (scale bars = 200 µm). C Histologic evaluation scores demonstrating that hUCMSCs could inhibit necrosis, fibrosis and improve adipose proportion in grafted tissue. D , E The diameter of adipocytes was measured and classified in different groups, and the low hUCMSC group holds the highest proportion of mature adipocytes among four groups (* P < 0.05, ** P < 0.01, *** P < 0.001). F The low hUCMSC group holds the lowest cavitary necrosis area and fibrosis degree, but the highest fat tissue occupation among four groups

Journal: Stem Cell Research & Therapy

Article Title: Human umbilical cord mesenchymal stem cell promotes angiogenesis via integrin β1/ERK1/2/HIF-1α/VEGF-A signaling pathway for off-the-shelf breast tissue engineering

doi: 10.1186/s13287-022-02770-x

Figure Lengend Snippet: HUCMSCs transplantation promoted the survival of adipose tissue in fat graft without breast scaffold. A After 12 weeks of implantation, all the tissue was measured and photographed. The retention rates of grafted fat in the Low hUCMSC group and Medium hUCMSC group were significantly higher than that of the Control group (* P < 0.05, ** P < 0.001). B HE staining of fat tissue after 12 weeks of implantation (black arrows: fibrosis; stars: cysts or vacuoles; red arrows: blood vessels (scale bars = 200 µm). C Histologic evaluation scores demonstrating that hUCMSCs could inhibit necrosis, fibrosis and improve adipose proportion in grafted tissue. D , E The diameter of adipocytes was measured and classified in different groups, and the low hUCMSC group holds the highest proportion of mature adipocytes among four groups (* P < 0.05, ** P < 0.01, *** P < 0.001). F The low hUCMSC group holds the lowest cavitary necrosis area and fibrosis degree, but the highest fat tissue occupation among four groups

Article Snippet: Cells were cultured at 37 °C in 5% CO 2 95% air-humidified incubator, harvested using 0.05% trypsin, centrifuged and resuspended in hUCMSCs complete medium (Cyagen Biosciences, USA).

Techniques: Transplantation Assay, Control, Staining

HUCMSCs promoted angiogenesis, attenuated macrophage infiltration, and adipocyte or endothelial differentiation in the adipose tissue. A Images of adipocytes (green fluorescence) and blood vessels (red fluorescence). The proportions of CD31 + area in each hUCMSC group were significantly higher than the Control group (Scale bars = 200 µm; *** P < 0.001). B The distribution of M1 and M2 macrophages (white triangles: M1 macrophages; yellow triangles: M2 macrophages). The numbers of M1 macrophages in the Low hUCMSC group and High hUCMSC group were significantly smaller than the Control group. In terms of M2 macrophages, no significant difference was found between all four groups (scale bars = 100 µm; ** P < 0.01, *** P < 0.001). C Some transplanted hUCMSCs (CM-Dil-labeled, red fluorescence) were positive expression for Perilipin or CD31 (Scale bars = 25 µm)

Journal: Stem Cell Research & Therapy

Article Title: Human umbilical cord mesenchymal stem cell promotes angiogenesis via integrin β1/ERK1/2/HIF-1α/VEGF-A signaling pathway for off-the-shelf breast tissue engineering

doi: 10.1186/s13287-022-02770-x

Figure Lengend Snippet: HUCMSCs promoted angiogenesis, attenuated macrophage infiltration, and adipocyte or endothelial differentiation in the adipose tissue. A Images of adipocytes (green fluorescence) and blood vessels (red fluorescence). The proportions of CD31 + area in each hUCMSC group were significantly higher than the Control group (Scale bars = 200 µm; *** P < 0.001). B The distribution of M1 and M2 macrophages (white triangles: M1 macrophages; yellow triangles: M2 macrophages). The numbers of M1 macrophages in the Low hUCMSC group and High hUCMSC group were significantly smaller than the Control group. In terms of M2 macrophages, no significant difference was found between all four groups (scale bars = 100 µm; ** P < 0.01, *** P < 0.001). C Some transplanted hUCMSCs (CM-Dil-labeled, red fluorescence) were positive expression for Perilipin or CD31 (Scale bars = 25 µm)

Article Snippet: Cells were cultured at 37 °C in 5% CO 2 95% air-humidified incubator, harvested using 0.05% trypsin, centrifuged and resuspended in hUCMSCs complete medium (Cyagen Biosciences, USA).

Techniques: Fluorescence, Control, Labeling, Expressing

HUCMSCs improved angiogenesis and fat proportion in fat graft with breast scaffold. A Scheme of breast tissue engineering construct and the harvested implants. B HUCMSCs significantly improved the volumes and mass of the scaffold compounds after 12 weeks of implantation. C HE staining of scaffold compounds was shown in (Stars: cysts or vacuoles; Scale bars = 200 µm). D HUCMSCs inhibited fibrosis and improved the fat proportion in implants (* P < 0.05, ** P < 0.01, *** P < 0.001). E HUCMSCs also significantly decreased the thickness of the fibrous capsule of implants (* P < 0.05, ** P < 0.01, *** P < 0.001). F HUCMSCs significantly increased the area of blood vessels (CD31 + , green fluorescence) in the engineered breast tissue (scale bars = 100 µm). G HUCMSCs significantly decreased the number of macrophages (CD68 + , green fluorescence, depicted by white triangles) in the implants. (Scale bars = 100 µm)

Journal: Stem Cell Research & Therapy

Article Title: Human umbilical cord mesenchymal stem cell promotes angiogenesis via integrin β1/ERK1/2/HIF-1α/VEGF-A signaling pathway for off-the-shelf breast tissue engineering

doi: 10.1186/s13287-022-02770-x

Figure Lengend Snippet: HUCMSCs improved angiogenesis and fat proportion in fat graft with breast scaffold. A Scheme of breast tissue engineering construct and the harvested implants. B HUCMSCs significantly improved the volumes and mass of the scaffold compounds after 12 weeks of implantation. C HE staining of scaffold compounds was shown in (Stars: cysts or vacuoles; Scale bars = 200 µm). D HUCMSCs inhibited fibrosis and improved the fat proportion in implants (* P < 0.05, ** P < 0.01, *** P < 0.001). E HUCMSCs also significantly decreased the thickness of the fibrous capsule of implants (* P < 0.05, ** P < 0.01, *** P < 0.001). F HUCMSCs significantly increased the area of blood vessels (CD31 + , green fluorescence) in the engineered breast tissue (scale bars = 100 µm). G HUCMSCs significantly decreased the number of macrophages (CD68 + , green fluorescence, depicted by white triangles) in the implants. (Scale bars = 100 µm)

Article Snippet: Cells were cultured at 37 °C in 5% CO 2 95% air-humidified incubator, harvested using 0.05% trypsin, centrifuged and resuspended in hUCMSCs complete medium (Cyagen Biosciences, USA).

Techniques: Construct, Staining, Fluorescence

Mechanisms of hUCMSCs injection in breast tissue engineering. HUCMSCs could promote vascularization in vitro via paracrine, which could activate the vital signal pathway of integrin β1/ERK1/2/HIF-1α/VEGF-A in endothelial cells. Moreover, hUCMSCs exerted an immunomodulatory effect by inhibiting M1 macrophages and differentiate into adipocytes and vascular endothelial cells in vivo

Journal: Stem Cell Research & Therapy

Article Title: Human umbilical cord mesenchymal stem cell promotes angiogenesis via integrin β1/ERK1/2/HIF-1α/VEGF-A signaling pathway for off-the-shelf breast tissue engineering

doi: 10.1186/s13287-022-02770-x

Figure Lengend Snippet: Mechanisms of hUCMSCs injection in breast tissue engineering. HUCMSCs could promote vascularization in vitro via paracrine, which could activate the vital signal pathway of integrin β1/ERK1/2/HIF-1α/VEGF-A in endothelial cells. Moreover, hUCMSCs exerted an immunomodulatory effect by inhibiting M1 macrophages and differentiate into adipocytes and vascular endothelial cells in vivo

Article Snippet: Cells were cultured at 37 °C in 5% CO 2 95% air-humidified incubator, harvested using 0.05% trypsin, centrifuged and resuspended in hUCMSCs complete medium (Cyagen Biosciences, USA).

Techniques: Injection, In Vitro, In Vivo

hUVECs with hUCMSCs, hiPSC-MSCs, hESC-MSCs and hBMSCs had capillary-like structures. (A–D) Typical fluorescent images of coculture at 6 weeks with microcapillary structures on macroporous CPC-RGD. (E) Cumulative microcapillary length per scaffold surface area (mean ± sd; n = 5). hUCMSCs = UCM. hUVECs = EC. hiPSC-MSCs = iPM. hESC-MSCs = ESM. hBMSCs = BM. Week = w. Values that share the same letter (for example, the four groups at 6 weeks share the same letter a) are not significantly different from each other (p > 0.1). Values indicated by different letters (without any letter that is the same) are significantly different from each other (p < 0.05).

Journal: Journal of tissue engineering and regenerative medicine

Article Title: Angiogenic and osteogenic regeneration in rats via calcium phosphate scaffold and endothelial cell coculture with hBMSCs, hUCMSCs, hiPSC-MSCs and hESC-MSCs

doi: 10.1002/term.2395

Figure Lengend Snippet: hUVECs with hUCMSCs, hiPSC-MSCs, hESC-MSCs and hBMSCs had capillary-like structures. (A–D) Typical fluorescent images of coculture at 6 weeks with microcapillary structures on macroporous CPC-RGD. (E) Cumulative microcapillary length per scaffold surface area (mean ± sd; n = 5). hUCMSCs = UCM. hUVECs = EC. hiPSC-MSCs = iPM. hESC-MSCs = ESM. hBMSCs = BM. Week = w. Values that share the same letter (for example, the four groups at 6 weeks share the same letter a) are not significantly different from each other (p > 0.1). Values indicated by different letters (without any letter that is the same) are significantly different from each other (p < 0.05).

Article Snippet: Furthermore, HLA-ABC was expressed at 94.1%, whereas HLA-DR, TRA-1-81 and Oct3/4 were absent, which is characteristic for MSCs ( Tang et al., 2012 ; Chen et al., 2013 ). hUCMSCs were obtained from Lonza (Walkersville, MD) and cultured in MSC growth media, including low-glucose Dulbecco’s modified Eagle’s medium (DMEM) with 10% fetal bovine serum (FBS) and 1% penicillin/streptomycin (PS) (Invitrogen, Carlsbad, CA). hBMSCs (Lonza) were cultured in hBMSC growth medium, which consisted of DMEM plus 10% FBS, 1% PS, 0.25% gentamicin and 0.25% fungizone (Invitrogen). hUVECs (Lonza) were cultured in endothelial cell growth medium-2 (EGM-2; Lonza) consisting of endothelial cells basal medium-2 (EBM-2; Lonza) and a provided kit (Lonza) in a humidified incubator (5% CO 2 , 37 °C) following a previous study ( Xu and Thein-Han, 2013 ).

Techniques:

Osteogenic and angiogenic gene expressions of cocultured hUVECs and MSCs: (A) ALP; (B) OC; (C) COL I; (D) VEGF; (E) VE-cadherin; and (F) vWF (mean ± SD; n = 5). hUCMSCs = UCM. hUVECs = EC. hiPSC-MSCs = iPM. hESC-MSCs = ESM. hBMSCs = BM. Week = w. In each plot, values that share the same letter are not significantly different from each other (p > 0.1). Values indicated by different letters (without any letter that is the same) are significantly different from each other (p < 0.05).

Journal: Journal of tissue engineering and regenerative medicine

Article Title: Angiogenic and osteogenic regeneration in rats via calcium phosphate scaffold and endothelial cell coculture with hBMSCs, hUCMSCs, hiPSC-MSCs and hESC-MSCs

doi: 10.1002/term.2395

Figure Lengend Snippet: Osteogenic and angiogenic gene expressions of cocultured hUVECs and MSCs: (A) ALP; (B) OC; (C) COL I; (D) VEGF; (E) VE-cadherin; and (F) vWF (mean ± SD; n = 5). hUCMSCs = UCM. hUVECs = EC. hiPSC-MSCs = iPM. hESC-MSCs = ESM. hBMSCs = BM. Week = w. In each plot, values that share the same letter are not significantly different from each other (p > 0.1). Values indicated by different letters (without any letter that is the same) are significantly different from each other (p < 0.05).

Article Snippet: Furthermore, HLA-ABC was expressed at 94.1%, whereas HLA-DR, TRA-1-81 and Oct3/4 were absent, which is characteristic for MSCs ( Tang et al., 2012 ; Chen et al., 2013 ). hUCMSCs were obtained from Lonza (Walkersville, MD) and cultured in MSC growth media, including low-glucose Dulbecco’s modified Eagle’s medium (DMEM) with 10% fetal bovine serum (FBS) and 1% penicillin/streptomycin (PS) (Invitrogen, Carlsbad, CA). hBMSCs (Lonza) were cultured in hBMSC growth medium, which consisted of DMEM plus 10% FBS, 1% PS, 0.25% gentamicin and 0.25% fungizone (Invitrogen). hUVECs (Lonza) were cultured in endothelial cell growth medium-2 (EGM-2; Lonza) consisting of endothelial cells basal medium-2 (EBM-2; Lonza) and a provided kit (Lonza) in a humidified incubator (5% CO 2 , 37 °C) following a previous study ( Xu and Thein-Han, 2013 ).

Techniques:

Cocultured cell mineralization on macroporous CPC-RGD: (A) ARS of minerals by cells on CPC-RGD at 6 weeks, and (B) cell-synthesized mineral concentration (mean ± sd; n = 6). hUCMSCs = UCM. hUVECs = EC. hiPSC-MSCs = iPM. hESC-MSCs = ESM. hBMSCs = BM. Week = w. Values that share the same letter are not significantly different from each other (p > 0.1). Values indicated by different letters (without any letter that is the same) are significantly different from each other (p < 0.05).

Journal: Journal of tissue engineering and regenerative medicine

Article Title: Angiogenic and osteogenic regeneration in rats via calcium phosphate scaffold and endothelial cell coculture with hBMSCs, hUCMSCs, hiPSC-MSCs and hESC-MSCs

doi: 10.1002/term.2395

Figure Lengend Snippet: Cocultured cell mineralization on macroporous CPC-RGD: (A) ARS of minerals by cells on CPC-RGD at 6 weeks, and (B) cell-synthesized mineral concentration (mean ± sd; n = 6). hUCMSCs = UCM. hUVECs = EC. hiPSC-MSCs = iPM. hESC-MSCs = ESM. hBMSCs = BM. Week = w. Values that share the same letter are not significantly different from each other (p > 0.1). Values indicated by different letters (without any letter that is the same) are significantly different from each other (p < 0.05).

Article Snippet: Furthermore, HLA-ABC was expressed at 94.1%, whereas HLA-DR, TRA-1-81 and Oct3/4 were absent, which is characteristic for MSCs ( Tang et al., 2012 ; Chen et al., 2013 ). hUCMSCs were obtained from Lonza (Walkersville, MD) and cultured in MSC growth media, including low-glucose Dulbecco’s modified Eagle’s medium (DMEM) with 10% fetal bovine serum (FBS) and 1% penicillin/streptomycin (PS) (Invitrogen, Carlsbad, CA). hBMSCs (Lonza) were cultured in hBMSC growth medium, which consisted of DMEM plus 10% FBS, 1% PS, 0.25% gentamicin and 0.25% fungizone (Invitrogen). hUVECs (Lonza) were cultured in endothelial cell growth medium-2 (EGM-2; Lonza) consisting of endothelial cells basal medium-2 (EBM-2; Lonza) and a provided kit (Lonza) in a humidified incubator (5% CO 2 , 37 °C) following a previous study ( Xu and Thein-Han, 2013 ).

Techniques: Synthesized, Concentration Assay

Identification of JD-312 as compound that promotes cartilage differentiation A) Schematic of drug screening strategy. B) JD-312 increases chondrocyte-specific gene expression in hUCMSCs (JD-312, 10 μM. KGN, 10 μM). Cells were incubated for 7 days to detect mRNA expression levels via RT-qPCR (n = 3). Type II Collagen, Col2a1 . Aggrecan, Acan . C) The protein levels of Col2 and ACAN in hUCMSCs were analysed by western blotting. D) Effect of JD-312 on cell viability of hUCMSCs detected by CCK8 assay (n = 3).

Journal: Journal of Orthopaedic Translation

Article Title: JD-312 – A novel small molecule that facilitates cartilage repair and alleviates osteoarthritis progression

doi: 10.1016/j.jot.2023.11.007

Figure Lengend Snippet: Identification of JD-312 as compound that promotes cartilage differentiation A) Schematic of drug screening strategy. B) JD-312 increases chondrocyte-specific gene expression in hUCMSCs (JD-312, 10 μM. KGN, 10 μM). Cells were incubated for 7 days to detect mRNA expression levels via RT-qPCR (n = 3). Type II Collagen, Col2a1 . Aggrecan, Acan . C) The protein levels of Col2 and ACAN in hUCMSCs were analysed by western blotting. D) Effect of JD-312 on cell viability of hUCMSCs detected by CCK8 assay (n = 3).

Article Snippet: We used a micromass culture of hUCMSCs to validate the effectiveness of JD-312 in inducing chondrogenic differentiation.

Techniques: Drug discovery, Gene Expression, Incubation, Expressing, Quantitative RT-PCR, Western Blot, CCK-8 Assay

JD-312 promotes the chondrogenic differentiation of hUCMSCs in vitro . A) Alcian blue staining showing the effect of JD-312 on chondrogenic differentiation of hUCMSCs. B) RT-qPCR analysis of Col2a1 and Acan mRNA expression in hUCMSCs treated with varying concentrations of JD-312. C) Alcian blue staining showing the effect of JD-312 (10 μM) on chondrogenic differentiation of hUCMSCs over time. D) RT-qPCR analysis of Col2a1 and Acan mRNA expression over time in hUCMSCs treated with JD-312. E) Macroscopic images of 3D micromass cultures of hUCMSCs treated with kartogenin (KGN) and JD-312. F) illustrates the weight of 3D micromass cultures shown in E. G) The concentration of glycosaminoglycan (GAG) released in the culture supernatant of the 3D micromass cultures at 21 days. (*P < 0.05, **P < 0.01, ***P < 0.001). (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.)

Journal: Journal of Orthopaedic Translation

Article Title: JD-312 – A novel small molecule that facilitates cartilage repair and alleviates osteoarthritis progression

doi: 10.1016/j.jot.2023.11.007

Figure Lengend Snippet: JD-312 promotes the chondrogenic differentiation of hUCMSCs in vitro . A) Alcian blue staining showing the effect of JD-312 on chondrogenic differentiation of hUCMSCs. B) RT-qPCR analysis of Col2a1 and Acan mRNA expression in hUCMSCs treated with varying concentrations of JD-312. C) Alcian blue staining showing the effect of JD-312 (10 μM) on chondrogenic differentiation of hUCMSCs over time. D) RT-qPCR analysis of Col2a1 and Acan mRNA expression over time in hUCMSCs treated with JD-312. E) Macroscopic images of 3D micromass cultures of hUCMSCs treated with kartogenin (KGN) and JD-312. F) illustrates the weight of 3D micromass cultures shown in E. G) The concentration of glycosaminoglycan (GAG) released in the culture supernatant of the 3D micromass cultures at 21 days. (*P < 0.05, **P < 0.01, ***P < 0.001). (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.)

Article Snippet: We used a micromass culture of hUCMSCs to validate the effectiveness of JD-312 in inducing chondrogenic differentiation.

Techniques: In Vitro, Staining, Quantitative RT-PCR, Expressing, Concentration Assay

JD-312 treated hUCMSCs enhances cartilage repair after DMM surgery in SD rats A) Representative images of Safranin-O staining of knee joints following sham operation or DMM in rats which were treated with hUCMSCs (MSC), or hUCMSCs transiently induced with KGN (KGN + MSC) or JD-312 (JD-312+MSC), with PBS as control. Scale bar = 400 μm. The OARSI scores for the sections are reported in B) . Knee joint sections were stained with antibodies against Col2 and ACAN and the expression is quantified in C) . n = 6 per group. Red, Col2a1, ACAN; Blue, DAPI. (*P < 0.05, **P < 0.01, ***P < 0.001). (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.)

Journal: Journal of Orthopaedic Translation

Article Title: JD-312 – A novel small molecule that facilitates cartilage repair and alleviates osteoarthritis progression

doi: 10.1016/j.jot.2023.11.007

Figure Lengend Snippet: JD-312 treated hUCMSCs enhances cartilage repair after DMM surgery in SD rats A) Representative images of Safranin-O staining of knee joints following sham operation or DMM in rats which were treated with hUCMSCs (MSC), or hUCMSCs transiently induced with KGN (KGN + MSC) or JD-312 (JD-312+MSC), with PBS as control. Scale bar = 400 μm. The OARSI scores for the sections are reported in B) . Knee joint sections were stained with antibodies against Col2 and ACAN and the expression is quantified in C) . n = 6 per group. Red, Col2a1, ACAN; Blue, DAPI. (*P < 0.05, **P < 0.01, ***P < 0.001). (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.)

Article Snippet: We used a micromass culture of hUCMSCs to validate the effectiveness of JD-312 in inducing chondrogenic differentiation.

Techniques: Staining, Control, Expressing

Identifying the molecular mechanisms that govern JD-312's chondrogenic effect in hUCMSCS A) Volcano plots depicting the differentially expressed genes between hUCMSCs treated with JD-312 (10 μM) after 7 days. B and C) KEGG and GSEA enrichment analysis of the differentially expressed genes. D) Heatmap depicting the fold changes of differentially expressed genes associated with the Focal adhesion, PI3K-Akt, and ECM-receptor interaction pathways highlighted.

Journal: Journal of Orthopaedic Translation

Article Title: JD-312 – A novel small molecule that facilitates cartilage repair and alleviates osteoarthritis progression

doi: 10.1016/j.jot.2023.11.007

Figure Lengend Snippet: Identifying the molecular mechanisms that govern JD-312's chondrogenic effect in hUCMSCS A) Volcano plots depicting the differentially expressed genes between hUCMSCs treated with JD-312 (10 μM) after 7 days. B and C) KEGG and GSEA enrichment analysis of the differentially expressed genes. D) Heatmap depicting the fold changes of differentially expressed genes associated with the Focal adhesion, PI3K-Akt, and ECM-receptor interaction pathways highlighted.

Article Snippet: We used a micromass culture of hUCMSCs to validate the effectiveness of JD-312 in inducing chondrogenic differentiation.

Techniques:

(A) Cell wound healing assay for IL-1β stimulated mesenchymal stem cells in the presence or absence of 2 μg/ml IL-1RA (IL-1β inhibitor) at 12 and 24 hours. Scale bars = 300 μm. (B) The wound area of hUCMSCs were indicated by MetaMorph and the data were normalized with control and shown as the mean ± SD (n = 3, *P<0.05, **P<0.01 versus control cells, #p<0.05, ##p<0.01 versus IL-1β treated cells). (C) Cell viability assay for IL-1β stimulation. Data were quantified by multimode micro-plate readers. Data are shown as the mean ± SD (n = 3) (N.S.: nonsignificance).

Journal: PLoS ONE

Article Title: Interleukin-1β-induced matrix metalloproteinase-3 via ERK1/2 pathway to promote mesenchymal stem cell migration

doi: 10.1371/journal.pone.0252163

Figure Lengend Snippet: (A) Cell wound healing assay for IL-1β stimulated mesenchymal stem cells in the presence or absence of 2 μg/ml IL-1RA (IL-1β inhibitor) at 12 and 24 hours. Scale bars = 300 μm. (B) The wound area of hUCMSCs were indicated by MetaMorph and the data were normalized with control and shown as the mean ± SD (n = 3, *P<0.05, **P<0.01 versus control cells, #p<0.05, ##p<0.01 versus IL-1β treated cells). (C) Cell viability assay for IL-1β stimulation. Data were quantified by multimode micro-plate readers. Data are shown as the mean ± SD (n = 3) (N.S.: nonsignificance).

Article Snippet: Human umbilical cord derived mesenchymal stem cells (hUCMSCs) were purchased from Bioresource Collection and Research Center, Hsinchu, Taiwan. hUCMSCs were cultured in low serum defined medium consisting of 56% low-glucose Dulbecco’s Modified Eagle Medium (DMEM-LG; Invitrogen, CA, USA), 37% MCBD 201 (Sigma, MO, USA), 2% fetal bovine serum (Thermo, Logan, UT), 0.5 mg/ml of AlbuMAX® I (Invitrogen, CA, USA), 1X insulin-transferrin-selenium-A (Invitrogen, CA, USA), 1X antibiotic antimycotic solution (Thermo, Logan, UT), 10 nM dexamethasone (Sigma, MO, USA), 50 nM L-ascorbic acid 2-phosphate (Sigma, MO, USA), 10 ng/ml of epidermal growth factor (PeproTech, NJ, USA), and 1 ng/ml of platelet-derived growth factor-BB (PeproTech, NJ, USA) at 37°C and 5% CO 2 .

Techniques: Wound Healing Assay, Control, Viability Assay

Total RNA microarray based screening for the expression of MMPs with IL-1β stimulation for 24 hours in  mesenchymal  stem cells.

Journal: PLoS ONE

Article Title: Interleukin-1β-induced matrix metalloproteinase-3 via ERK1/2 pathway to promote mesenchymal stem cell migration

doi: 10.1371/journal.pone.0252163

Figure Lengend Snippet: Total RNA microarray based screening for the expression of MMPs with IL-1β stimulation for 24 hours in mesenchymal stem cells.

Article Snippet: Human umbilical cord derived mesenchymal stem cells (hUCMSCs) were purchased from Bioresource Collection and Research Center, Hsinchu, Taiwan. hUCMSCs were cultured in low serum defined medium consisting of 56% low-glucose Dulbecco’s Modified Eagle Medium (DMEM-LG; Invitrogen, CA, USA), 37% MCBD 201 (Sigma, MO, USA), 2% fetal bovine serum (Thermo, Logan, UT), 0.5 mg/ml of AlbuMAX® I (Invitrogen, CA, USA), 1X insulin-transferrin-selenium-A (Invitrogen, CA, USA), 1X antibiotic antimycotic solution (Thermo, Logan, UT), 10 nM dexamethasone (Sigma, MO, USA), 50 nM L-ascorbic acid 2-phosphate (Sigma, MO, USA), 10 ng/ml of epidermal growth factor (PeproTech, NJ, USA), and 1 ng/ml of platelet-derived growth factor-BB (PeproTech, NJ, USA) at 37°C and 5% CO 2 .

Techniques: Microarray, Expressing

(A) Quantitation of changes in gene expression of MMP-3 detected by real-time PCR. hUCMSCs were transfected with MMP-3 siRNA and stimulated with IL-1β for 24 hours. (B) MMP-3 protein expression was measured using ELISA, transfected with MMP-3 siRNA and stimulated with IL-1β for 36 hours. (C) Cell wound healing assay for IL-1β stimulated mesenchymal stem cells after MMP-3 siRNA transfection. Scale bars = 300 μm. (D) The wound area of hUCMSCs were indicated by MetaMorph. (E) Cell invasion assay for IL-1β stimulated mesenchymal stem cells after MMP-3 siRNA transfection. Scale bars = 1 mm. (F) Graph indicates the invasion ability of stem cells. Data are shown as the mean ± SD (n = 3, **P<0.01, ***P<0.005 versus control cells, #p<0.05, ##p<0.01, ###p<0.005, versus IL-1β treated cells).

Journal: PLoS ONE

Article Title: Interleukin-1β-induced matrix metalloproteinase-3 via ERK1/2 pathway to promote mesenchymal stem cell migration

doi: 10.1371/journal.pone.0252163

Figure Lengend Snippet: (A) Quantitation of changes in gene expression of MMP-3 detected by real-time PCR. hUCMSCs were transfected with MMP-3 siRNA and stimulated with IL-1β for 24 hours. (B) MMP-3 protein expression was measured using ELISA, transfected with MMP-3 siRNA and stimulated with IL-1β for 36 hours. (C) Cell wound healing assay for IL-1β stimulated mesenchymal stem cells after MMP-3 siRNA transfection. Scale bars = 300 μm. (D) The wound area of hUCMSCs were indicated by MetaMorph. (E) Cell invasion assay for IL-1β stimulated mesenchymal stem cells after MMP-3 siRNA transfection. Scale bars = 1 mm. (F) Graph indicates the invasion ability of stem cells. Data are shown as the mean ± SD (n = 3, **P<0.01, ***P<0.005 versus control cells, #p<0.05, ##p<0.01, ###p<0.005, versus IL-1β treated cells).

Article Snippet: Human umbilical cord derived mesenchymal stem cells (hUCMSCs) were purchased from Bioresource Collection and Research Center, Hsinchu, Taiwan. hUCMSCs were cultured in low serum defined medium consisting of 56% low-glucose Dulbecco’s Modified Eagle Medium (DMEM-LG; Invitrogen, CA, USA), 37% MCBD 201 (Sigma, MO, USA), 2% fetal bovine serum (Thermo, Logan, UT), 0.5 mg/ml of AlbuMAX® I (Invitrogen, CA, USA), 1X insulin-transferrin-selenium-A (Invitrogen, CA, USA), 1X antibiotic antimycotic solution (Thermo, Logan, UT), 10 nM dexamethasone (Sigma, MO, USA), 50 nM L-ascorbic acid 2-phosphate (Sigma, MO, USA), 10 ng/ml of epidermal growth factor (PeproTech, NJ, USA), and 1 ng/ml of platelet-derived growth factor-BB (PeproTech, NJ, USA) at 37°C and 5% CO 2 .

Techniques: Quantitation Assay, Gene Expression, Real-time Polymerase Chain Reaction, Transfection, Expressing, Enzyme-linked Immunosorbent Assay, Wound Healing Assay, Invasion Assay, Control

(A) Quantitation of changes in gene expression of MMP-3 detected by real-time PCR after ERK1/2 inhibitor U0126 (10–30 μM) treatment and stimulation with IL-1β for 24 hours. (B) Example of Western blot results of the MMP-3 (54 kDa) from the lysates of cells treated with IL-1β and ERK1/2 inhibitor U0126 (20 μM). The full-length Western blots was showed in . (C) Quantitative graphs of the Western blot results of MMP-3 protein expression of (B). (D) MMP-3 protein expression was measured using ELISA, treated with U0126 (20 μM) and stimulated with IL-1β for 36 hours. (E) MMP-3 activity was measured by Fluorogenic peptide Assays. hUCMSCs treated with U0126 at concentration of 20 μM. (F) Cell wound healing assay for IL-1β stimulated mesenchymal stem cells in the presence of ERK1/2 inhibitor U0126 (20 μM) at 24 hours. Scale bars = 300 μm. (G) The wound area of hUCMSCs were indicated by MetaMorph and the data were normalized with control and shown as the mean ± SD (n = 3, ***P<0.01 versus control cells, ##p<0.01 versus IL-1β treated cells). (H) Cell wound healing assay for IL-1β stimulated mesenchymal stem cells in the presence of ERK1/2 inhibitor U0126 (20 μM) at 24 hours. Scale bars = 1 mm. (I) Graph indicates the invasion ability of stem cells. Data are shown as the mean ± SD (n = 3, *P<0.05, *** P <0.005 versus control cells, #p<0.05, ##p<0.01, ###p<0.005 versus IL-1β treated cells).

Journal: PLoS ONE

Article Title: Interleukin-1β-induced matrix metalloproteinase-3 via ERK1/2 pathway to promote mesenchymal stem cell migration

doi: 10.1371/journal.pone.0252163

Figure Lengend Snippet: (A) Quantitation of changes in gene expression of MMP-3 detected by real-time PCR after ERK1/2 inhibitor U0126 (10–30 μM) treatment and stimulation with IL-1β for 24 hours. (B) Example of Western blot results of the MMP-3 (54 kDa) from the lysates of cells treated with IL-1β and ERK1/2 inhibitor U0126 (20 μM). The full-length Western blots was showed in . (C) Quantitative graphs of the Western blot results of MMP-3 protein expression of (B). (D) MMP-3 protein expression was measured using ELISA, treated with U0126 (20 μM) and stimulated with IL-1β for 36 hours. (E) MMP-3 activity was measured by Fluorogenic peptide Assays. hUCMSCs treated with U0126 at concentration of 20 μM. (F) Cell wound healing assay for IL-1β stimulated mesenchymal stem cells in the presence of ERK1/2 inhibitor U0126 (20 μM) at 24 hours. Scale bars = 300 μm. (G) The wound area of hUCMSCs were indicated by MetaMorph and the data were normalized with control and shown as the mean ± SD (n = 3, ***P<0.01 versus control cells, ##p<0.01 versus IL-1β treated cells). (H) Cell wound healing assay for IL-1β stimulated mesenchymal stem cells in the presence of ERK1/2 inhibitor U0126 (20 μM) at 24 hours. Scale bars = 1 mm. (I) Graph indicates the invasion ability of stem cells. Data are shown as the mean ± SD (n = 3, *P<0.05, *** P <0.005 versus control cells, #p<0.05, ##p<0.01, ###p<0.005 versus IL-1β treated cells).

Article Snippet: Human umbilical cord derived mesenchymal stem cells (hUCMSCs) were purchased from Bioresource Collection and Research Center, Hsinchu, Taiwan. hUCMSCs were cultured in low serum defined medium consisting of 56% low-glucose Dulbecco’s Modified Eagle Medium (DMEM-LG; Invitrogen, CA, USA), 37% MCBD 201 (Sigma, MO, USA), 2% fetal bovine serum (Thermo, Logan, UT), 0.5 mg/ml of AlbuMAX® I (Invitrogen, CA, USA), 1X insulin-transferrin-selenium-A (Invitrogen, CA, USA), 1X antibiotic antimycotic solution (Thermo, Logan, UT), 10 nM dexamethasone (Sigma, MO, USA), 50 nM L-ascorbic acid 2-phosphate (Sigma, MO, USA), 10 ng/ml of epidermal growth factor (PeproTech, NJ, USA), and 1 ng/ml of platelet-derived growth factor-BB (PeproTech, NJ, USA) at 37°C and 5% CO 2 .

Techniques: Quantitation Assay, Gene Expression, Real-time Polymerase Chain Reaction, Western Blot, Expressing, Enzyme-linked Immunosorbent Assay, Activity Assay, Concentration Assay, Wound Healing Assay, Control

(A) Quantitation of changes in gene expression of MMP-3 detected by real-time PCR after p38 inhibitor (50 nM SB205380), Akt inhibitor (20 μM GSK690693), and JNK inhibitor (20 nM SP600125) treatment and stimulation with IL-1β for 24 hours. (B) Cell wound healing assay for IL-1β stimulated mesenchymal stem cells in the presence 50 nM SB205380, 20 μM GSK690693, and 20 nM SP600125 at 24 hours. Scale bars = 300 μm. (C) Graph indicates the migration ability of stem cells into the wound area. Data are shown as the mean ± SD (n = 3, *P<0.05, ***P<0.005 versus control cells, ###p<0.005 versus IL-1β treated cells).

Journal: PLoS ONE

Article Title: Interleukin-1β-induced matrix metalloproteinase-3 via ERK1/2 pathway to promote mesenchymal stem cell migration

doi: 10.1371/journal.pone.0252163

Figure Lengend Snippet: (A) Quantitation of changes in gene expression of MMP-3 detected by real-time PCR after p38 inhibitor (50 nM SB205380), Akt inhibitor (20 μM GSK690693), and JNK inhibitor (20 nM SP600125) treatment and stimulation with IL-1β for 24 hours. (B) Cell wound healing assay for IL-1β stimulated mesenchymal stem cells in the presence 50 nM SB205380, 20 μM GSK690693, and 20 nM SP600125 at 24 hours. Scale bars = 300 μm. (C) Graph indicates the migration ability of stem cells into the wound area. Data are shown as the mean ± SD (n = 3, *P<0.05, ***P<0.005 versus control cells, ###p<0.005 versus IL-1β treated cells).

Article Snippet: Human umbilical cord derived mesenchymal stem cells (hUCMSCs) were purchased from Bioresource Collection and Research Center, Hsinchu, Taiwan. hUCMSCs were cultured in low serum defined medium consisting of 56% low-glucose Dulbecco’s Modified Eagle Medium (DMEM-LG; Invitrogen, CA, USA), 37% MCBD 201 (Sigma, MO, USA), 2% fetal bovine serum (Thermo, Logan, UT), 0.5 mg/ml of AlbuMAX® I (Invitrogen, CA, USA), 1X insulin-transferrin-selenium-A (Invitrogen, CA, USA), 1X antibiotic antimycotic solution (Thermo, Logan, UT), 10 nM dexamethasone (Sigma, MO, USA), 50 nM L-ascorbic acid 2-phosphate (Sigma, MO, USA), 10 ng/ml of epidermal growth factor (PeproTech, NJ, USA), and 1 ng/ml of platelet-derived growth factor-BB (PeproTech, NJ, USA) at 37°C and 5% CO 2 .

Techniques: Quantitation Assay, Gene Expression, Real-time Polymerase Chain Reaction, Wound Healing Assay, Migration, Control

A: CM-Dil-labeled 3rd passage hucMSCs (×100); B: CM-Dil-labeled hucMSCs (×100) 7d later; C: CM-Dil-labeled hucMSCs membrane (×200).

Journal: International Journal of Ophthalmology

Article Title: Protective effects of human umbilical cord mesenchymal stem cells on retinal ganglion cells in mice with acute ocular hypertension

doi: 10.18240/ijo.2021.02.03

Figure Lengend Snippet: A: CM-Dil-labeled 3rd passage hucMSCs (×100); B: CM-Dil-labeled hucMSCs (×100) 7d later; C: CM-Dil-labeled hucMSCs membrane (×200).

Article Snippet: The 3 rd generation of hucMSCs line was obtained from the SALIAI Stemcell Science and Technology Co., Ltd. (Guangzhou, China).

Techniques: Labeling, Membrane

A: Normal; B: AOH; C: hucMSCs; D: NS. GCL: Ganglion cell layer; IPL: Inner plexus layer, INL: Inner nuclear layer, OPL: Outer plexus layer, ONL: Outer nuclear layer. AOH could significantly reduce the thickness of the inner retina. Intravitreal injection of hucMSCs could relieve the damage of AOH. Intravitreal injection of NS had no therapeutic effect on damage of AOH. aP<0.05.

Journal: International Journal of Ophthalmology

Article Title: Protective effects of human umbilical cord mesenchymal stem cells on retinal ganglion cells in mice with acute ocular hypertension

doi: 10.18240/ijo.2021.02.03

Figure Lengend Snippet: A: Normal; B: AOH; C: hucMSCs; D: NS. GCL: Ganglion cell layer; IPL: Inner plexus layer, INL: Inner nuclear layer, OPL: Outer plexus layer, ONL: Outer nuclear layer. AOH could significantly reduce the thickness of the inner retina. Intravitreal injection of hucMSCs could relieve the damage of AOH. Intravitreal injection of NS had no therapeutic effect on damage of AOH. aP<0.05.

Article Snippet: The 3 rd generation of hucMSCs line was obtained from the SALIAI Stemcell Science and Technology Co., Ltd. (Guangzhou, China).

Techniques: Injection

A: Normal; B: High eye pressure; C: NS; D: hucMSCs; E: Results showed that AOH model could lead to the obvious death of RGCs; injection of hucMSCs in vitreous cavity could reduce the mortality of RGCs (P<0.05); injection of NS had no effect on RGCs (P>0.05). aP<0.05; bP<0.01.

Journal: International Journal of Ophthalmology

Article Title: Protective effects of human umbilical cord mesenchymal stem cells on retinal ganglion cells in mice with acute ocular hypertension

doi: 10.18240/ijo.2021.02.03

Figure Lengend Snippet: A: Normal; B: High eye pressure; C: NS; D: hucMSCs; E: Results showed that AOH model could lead to the obvious death of RGCs; injection of hucMSCs in vitreous cavity could reduce the mortality of RGCs (P<0.05); injection of NS had no effect on RGCs (P>0.05). aP<0.05; bP<0.01.

Article Snippet: The 3 rd generation of hucMSCs line was obtained from the SALIAI Stemcell Science and Technology Co., Ltd. (Guangzhou, China).

Techniques: Injection